Transaction Trends 2023: Things Are Starting to Look Up

Following the excesses of 2020 and 2021, which produced some of the most exuberant life sciences activity in decades, activity was anemic for both merger and acquisitions (M&A) and initial public offerings (IPOs). Rising interest rates, prompted by inflationary pressures, rose from a low in spring of 2021 to a recent peak in October 2023.…

Read More